abs358.txt	background		there	are	multiple	known	individual-	and	practice-level	barriers	toenrollment	of	older	patients	with	cancer	to	clinical	trials	but	little	is	knownabout	how	the	research	workforce	feels	about	potential	higher-levelstrategy	changes	aimed	promote	increased	enrollment	subjects	materials	methods	we	invited	all	11	351	alliance	for	clinicaltrials	in	oncology	(	)	members	participate	an	anonymous	web-basedsurvey	examine	awareness	current	accrual	patterns	toclinical	ascertain	consensus	on	tackle	challenges	provide	impetus	high-level	improve	trialaccrual	results	during	period	from	february	28	2017	june	16	1	146alliance	participated	(response	rate	=	10%)	including	a	national	diversesample	physicians	nurses	administrative/clinical	staff	patientadvocates	representation	community	academic	rural	sites	overall	one	third	felt	that	>50%	trial	enrollees	should	be	age	≥65	64	9%felt	could	upon	four	mostcommonly	ranked	strategies	were	creatingmore	dedicated	this	population	(36	3%)	minimizing	exclusion	criteriafocused	comorbidity	(35	5%)	developing	independent	those	aged≥65	aged	≥70	(33	2%)	requiring	most/all	trialshave	specific	expansion	cohort	(30	0%)	conclusion	anticipate	recommendations	>1	000	memberswill	continue	propel	important	strategy	ofolder	implications	practice	survey	trialsmembership	sought	opinions	large-scale	toimprove	adults	was	found	around	multiplestrategies	creating	more	less	stringent	eligibility	criteria	mandating	cohortsof	within	broader	it	anticipated	therecommendations	will	importantstrategy
